today show glp-1 Dr. John Buse spoke with NBC News about a trial for a new monthly shot. He discussed how patients "really like the idea" of a once-monthly dose, and that the new Understanding GLP-1 Treatments for Perimenopause

Multi-lasso peptide-based synergistic nanocomposite: a high-stability, broad-spectrum antimicrobial agent with potential for combined antibacterial therapy

Oral administration of NAC (600 mg every 8 h) to COVID-19 patients ( n = 19,208) with high-risk comorbidities (i.e., hypertension, dyslipidemia, diabetes, and COPD) is shown to significantly lower mortality rate 607

clinical data is demonstrating their efficacy in treating fatty liver disease, cardiovascular conditions, and neurological disorders

"Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency." Am J Clin Nutr

for other GLP-1 medications, follow specific label guidance

Handbook of Brewing (2nd ed.)